Fennec Pharma
Last update: November 6, 2020
Biotechnology
United States (USA)
Its 9 main executives
Create an alert
to follow the executive moves at Fennec Pharma.
Fennec Pharma is one of the...
Most searched biographies at Fennec Pharma
- Rostislav Raykov, Director and Chief Executive Officer
- Khalid Islam, Chairman of the Board
- Marco Brughera, Director
Click on an executive to view his biography >
Latest M&A news in Biotechnology.
Kymab and Sanofi have announced they will merge (posted on Jan 11, 2021).
PerkinElmer has announced the acquisition of Oxford Immunotec (posted on Jan 8, 2021).
Syneos Health has announced the acquisition of SynteractHCR (posted on Dec 18, 2020).
Other contacts in the Biotechnology industry
Latest news about Fennec Pharma
Fennec Announces Issuance of U.S. Patent for PEDMARK™ | Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences | Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors | Fennec Pharmaceuticals In
Fennec Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update | Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility | Fennec Pharmaceuticals Inc.
Fennec Pharma on Wikipedia, Google News & Yahoo Finance
Fennec Pharma on LinkedIn, Twitter & YouTube
Fennec Pharma has 1,539 competitors including Biogen (United States (USA)), Agilyx (United States (USA)) and Eurofins (France).
